Boston Scientific (BSX) Net Margin (2009 - 2026)

Boston Scientific has disclosed Net Margin across 18 years of filings, most recently posting 16.67% for Q2 2026.

• In Q2 2026, Net Margin rose 92.0% year-over-year to 16.67%; the TTM figure through Jun 2026 stood at 17.5% (up 396.0% YoY), while the FY2025 annual figure was 14.44%, up 337.0% from the prior year.
• Net Margin came in at 16.67% for Q2 2026 at Boston Scientific, down from 25.77% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 25.77% in Q1 2026 to a low of 3.21% in Q1 2022.
• Average Net Margin over 5 years is 11.59%, with a median of 12.55% recorded in 2025.
• Year-over-year, Net Margin plunged 868 bps in 2022 and surged 1132 bps in 2026.
• Over 5 years, Net Margin stood at 3.89% in 2022, then jumped by 249 bps to 13.56% in 2023, then retreated by 9 bps to 12.39% in 2024, then gained by 3 bps to 12.71% in 2025, then surged by 31 bps to 16.67% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 16.67% in Q2 2026, 25.77% in Q1 2026, and 12.71% in Q4 2025.